Literature DB >> 14997560

Structural analysis of disease-causing mutations in the P-subfamily of forkhead transcription factors.

Sharmila Banerjee-Basu1, Andreas D Baxevanis.   

Abstract

Mutations in a number of forkhead transcription factors are associated with the development of inherited diseases in humans. Two closely related genes, FOXP2 and FOXP3, are implicated in two completely different human disorders. A point mutation in the forkhead domain of FOXP2 (R553H) is responsible for a severe speech and language disorder, while a series of missense mutations distributed over the forkhead domain of FOXP3 cause a fatal disorder called IPEX, characterized by immune dysregulation, polyendocrinopathy, and enteropathy. Homology model building techniques were used to generate atomic structures of FOXP2 and FOXP3, using the solution structures of the forkhead domain of the adipocyte-transcription factor FREAC-11 and AFX as templates. The impact of these disease-causing missense mutations on the three-dimensional structure, stability, and surface electrostatic charge distribution of the forkhead domains is examined here. The missense mutations R553H in FOXP2 and R397W in FOXP3 dramatically alter the electrostatic potentials of the molecular surface of their respective forkhead domains. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997560     DOI: 10.1002/prot.10621

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  9 in total

1.  Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.

Authors:  Estelle Bettelli; Maryam Dastrange; Mohamed Oukka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-24       Impact factor: 11.205

2.  A missense mutation in the transcription factor Foxo3a causes teratomas and oocyte abnormalities in mice.

Authors:  N A Youngson; N Vickaryous; A van der Horst; T Epp; S Harten; J S Fleming; K K Khanna; D M de Kretser; Emma Whitelaw
Journal:  Mamm Genome       Date:  2011-02-24       Impact factor: 2.957

3.  Genome-Wide Characterization, Evolutionary Analysis of ARF Gene Family, and the Role of SaARF4 in Cd Accumulation of Sedum alfredii Hance.

Authors:  Dong Xu; Chunyu Yang; Huijin Fan; Wenmin Qiu; Biyun Huang; Renying Zhuo; Zhengquan He; Haiying Li; Xiaojiao Han
Journal:  Plants (Basel)       Date:  2022-05-09

4.  Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1.

Authors:  Ushma R Jag; Jiri Zavadil; Frederick M Stanley
Journal:  Mol Endocrinol       Date:  2009-07-16

5.  FOXP3 renders activated human regulatory T cells resistant to restimulation-induced cell death by suppressing SAP expression.

Authors:  Gil Katz; Kelsey Voss; Toria F Yan; Yong Chan Kim; Robert L Kortum; David W Scott; Andrew L Snow
Journal:  Cell Immunol       Date:  2018-02-12       Impact factor: 4.868

6.  Alternative splicing and gene duplication in the evolution of the FoxP gene subfamily.

Authors:  M Emília Santos; Alekos Athanasiadis; Alexandre B Leitão; Louis DuPasquier; Elio Sucena
Journal:  Mol Biol Evol       Date:  2010-07-22       Impact factor: 16.240

7.  Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.

Authors:  Eleonora Gambineri; Sara Ciullini Mannurita; David Hagin; Marina Vignoli; Stephanie Anover-Sombke; Stacey DeBoer; Gesmar R S Segundo; Eric J Allenspach; Claudio Favre; Hans D Ochs; Troy R Torgerson
Journal:  Front Immunol       Date:  2018-11-01       Impact factor: 7.561

8.  Dissecting FOXP2 Oligomerization and DNA Binding.

Authors:  Katharina Häußermann; Gavin Young; Philipp Kukura; Hendrik Dietz
Journal:  Angew Chem Int Ed Engl       Date:  2019-04-29       Impact factor: 15.336

Review 9.  Intrauterine IPEX.

Authors:  Magda Carneiro-Sampaio; Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Jocelyne Demengeot; Antonio Coutinho
Journal:  Front Pediatr       Date:  2020-11-20       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.